These pathways are enriched significantly among genes that interact with Rotenone or its descendants. We show only terms with a corrected p-value <0.01.
| Pathway | Pathway ID | P-value | Corrected P-value | Annotated Genes | Genome Frequency | |
|---|---|---|---|---|---|---|
| 1. | Immune System | REACT:R-HSA-168256 | 9.47e-111 | 1.72e-107 | 239 | 2118/42493 genes: 4.98% |
| 2. | Metabolism | REACT:R-HSA-1430728 | 9.13e-98 | 1.65e-94 | 227 | 2172/42493 genes: 5.11% |
| 3. | Non-alcoholic fatty liver disease (NAFLD) | KEGG:hsa04932 | 2.42e-84 | 4.39e-81 | 74 | 149/42493 genes: 0.35% |
| 4. | Signal Transduction | REACT:R-HSA-162582 | 4.61e-84 | 8.36e-81 | 229 | 2587/42493 genes: 6.09% |
| 5. | Pathways in cancer | KEGG:hsa05200 | 3.45e-79 | 6.25e-76 | 100 | 395/42493 genes: 0.93% |
| 6. | Apoptosis | KEGG:hsa04210 | 6.10e-79 | 1.11e-75 | 69 | 138/42493 genes: 0.32% |
| 7. | Innate Immune System | REACT:R-HSA-168249 | 7.24e-76 | 1.31e-72 | 158 | 1298/42493 genes: 3.05% |
| 8. | Parkinson's disease | KEGG:hsa05012 | 1.96e-74 | 3.56e-71 | 67 | 142/42493 genes: 0.33% |
| 9. | Cellular responses to stress | REACT:R-HSA-2262752 | 4.59e-73 | 8.32e-70 | 100 | 451/42493 genes: 1.06% |
| 10. | Alzheimer's disease | KEGG:hsa05010 | 1.05e-70 | 1.91e-67 | 69 | 171/42493 genes: 0.40% |
| 11. | The citric acid (TCA) cycle and respiratory electron transport | REACT:R-HSA-1428517 | 8.65e-62 | 1.57e-58 | 63 | 170/42493 genes: 0.40% |
| 12. | Cytokine Signaling in Immune system | REACT:R-HSA-1280215 | 5.18e-61 | 9.38e-58 | 111 | 760/42493 genes: 1.79% |
| 13. | Fluid shear stress and atherosclerosis | KEGG:hsa05418 | 6.39e-60 | 1.16e-56 | 58 | 142/42493 genes: 0.33% |
| 14. | Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | REACT:R-HSA-163200 | 1.73e-57 | 3.14e-54 | 54 | 125/42493 genes: 0.29% |
| 15. | Huntington's disease | KEGG:hsa05016 | 2.52e-56 | 4.56e-53 | 62 | 193/42493 genes: 0.45% |
| 16. | Signaling by Interleukins | REACT:R-HSA-449147 | 2.52e-56 | 4.57e-53 | 91 | 528/42493 genes: 1.24% |
| 17. | Proteoglycans in cancer | KEGG:hsa05205 | 3.80e-56 | 6.89e-53 | 63 | 203/42493 genes: 0.48% |
| 18. | Hepatitis B | KEGG:hsa05161 | 6.49e-55 | 1.18e-51 | 55 | 144/42493 genes: 0.34% |
| 19. | Metabolic pathways | KEGG:hsa01100 | 8.58e-55 | 1.55e-51 | 132 | 1270/42493 genes: 2.99% |
| 20. | HIF-1 signaling pathway | KEGG:hsa04066 | 9.25e-54 | 1.68e-50 | 48 | 101/42493 genes: 0.24% |
| 21. | HTLV-I infection | KEGG:hsa05166 | 1.20e-51 | 2.18e-48 | 65 | 256/42493 genes: 0.60% |
| 22. | AGE-RAGE signaling pathway in diabetic complications | KEGG:hsa04933 | 5.60e-51 | 1.01e-47 | 46 | 99/42493 genes: 0.23% |
| 23. | Programmed Cell Death | REACT:R-HSA-5357801 | 7.51e-51 | 1.36e-47 | 56 | 175/42493 genes: 0.41% |
| 24. | Metabolism of proteins | REACT:R-HSA-392499 | 1.42e-50 | 2.57e-47 | 143 | 1624/42493 genes: 3.82% |
| 25. | Apoptosis | REACT:R-HSA-109581 | 6.12e-50 | 1.11e-46 | 55 | 172/42493 genes: 0.40% |
| 26. | Oxidative phosphorylation | KEGG:hsa00190 | 1.34e-49 | 2.43e-46 | 50 | 133/42493 genes: 0.31% |
| 27. | Transcriptional Regulation by TP53 | REACT:R-HSA-3700989 | 2.44e-47 | 4.42e-44 | 71 | 370/42493 genes: 0.87% |
| 28. | Gene Expression | REACT:R-HSA-74160 | 4.09e-47 | 7.40e-44 | 147 | 1831/42493 genes: 4.31% |
| 29. | Respiratory electron transport | REACT:R-HSA-611105 | 5.33e-47 | 9.66e-44 | 44 | 102/42493 genes: 0.24% |
| 30. | Cell Cycle | REACT:R-HSA-1640170 | 2.42e-45 | 4.39e-42 | 86 | 621/42493 genes: 1.46% |
| 31. | NOD-like receptor signaling pathway | KEGG:hsa04621 | 8.80e-45 | 1.59e-41 | 51 | 170/42493 genes: 0.40% |
| 32. | PI3K-Akt signaling pathway | KEGG:hsa04151 | 2.64e-44 | 4.79e-41 | 66 | 341/42493 genes: 0.80% |
| 33. | Adaptive Immune System | REACT:R-HSA-1280218 | 3.24e-44 | 5.88e-41 | 96 | 818/42493 genes: 1.93% |
| 34. | Disease | REACT:R-HSA-1643685 | 5.28e-44 | 9.56e-41 | 98 | 860/42493 genes: 2.02% |
| 35. | Signalling by NGF | REACT:R-HSA-166520 | 1.51e-43 | 2.73e-40 | 75 | 477/42493 genes: 1.12% |
| 36. | Fc epsilon receptor (FCERI) signaling | REACT:R-HSA-2454202 | 1.88e-43 | 3.40e-40 | 68 | 378/42493 genes: 0.89% |
| 37. | NGF signalling via TRKA from the plasma membrane | REACT:R-HSA-187037 | 1.18e-39 | 2.14e-36 | 65 | 387/42493 genes: 0.91% |
| 38. | Breast cancer | KEGG:hsa05224 | 3.49e-39 | 6.32e-36 | 44 | 144/42493 genes: 0.34% |
| 39. | Pancreatic cancer | KEGG:hsa05212 | 7.06e-39 | 1.28e-35 | 33 | 64/42493 genes: 0.15% |
| 40. | MAPK signaling pathway | KEGG:hsa04010 | 1.42e-38 | 2.57e-35 | 54 | 255/42493 genes: 0.60% |
| 41. | Generic Transcription Pathway | REACT:R-HSA-212436 | 1.57e-38 | 2.84e-35 | 92 | 873/42493 genes: 2.05% |
| 42. | TNF signaling pathway | KEGG:hsa04668 | 3.95e-38 | 7.16e-35 | 39 | 108/42493 genes: 0.25% |
| 43. | Tuberculosis | KEGG:hsa05152 | 3.19e-37 | 5.78e-34 | 46 | 178/42493 genes: 0.42% |
| 44. | Developmental Biology | REACT:R-HSA-1266738 | 3.86e-37 | 7.00e-34 | 100 | 1076/42493 genes: 2.53% |
| 45. | Interleukin-4 and 13 signaling | REACT:R-HSA-6785807 | 4.67e-37 | 8.46e-34 | 39 | 114/42493 genes: 0.27% |
| 46. | Signaling by VEGF | REACT:R-HSA-194138 | 4.75e-37 | 8.60e-34 | 59 | 338/42493 genes: 0.80% |
| 47. | Platinum drug resistance | KEGG:hsa01524 | 2.11e-36 | 3.82e-33 | 33 | 73/42493 genes: 0.17% |
| 48. | Neurotrophin signaling pathway | KEGG:hsa04722 | 3.22e-36 | 5.84e-33 | 39 | 119/42493 genes: 0.28% |
| 49. | Endocrine resistance | KEGG:hsa01522 | 3.45e-36 | 6.24e-33 | 36 | 95/42493 genes: 0.22% |
| 50. | Osteoclast differentiation | KEGG:hsa04380 | 5.09e-36 | 9.22e-33 | 40 | 129/42493 genes: 0.30% |